Skip to main content
How FABHALTA Works

HOW FABHALTA WORKS 

FABHALTA: A first-of-its-kind targeted IgAN treatment

In immunoglobulin A nephropathy (IgAN), unwanted IgA antibodies build up in your kidneys, leading to the activation of multiple pathways including a part of your immune system called the complement system.

FABHALTA® is the first and only FDA-approved treatment for adults with primary IgAN at risk of their disease worsening quickly, that targets the complement system.

Complement activation may play a role in IgAN development. Fabhalta targets the activated complement system to help block its impact in your kidneys.

Getting to Know FABHALTA With Dr Complement

Watch this video to meet Dr Complement and have him take you through several key points about FABHALTA, including how FABHALTA works, how it reduces your proteinuria, and how to get started.

Understanding Your IgAN

Understanding Your IgAN

Download this easy-to-understand brochure to learn about how IgAN impacts your kidneys and a few unfamiliar terms you may come across in your treatment journey.
Download

FABHALTA results

Get started on FABHALTA